АНАЛИЗ ЭФФЕКТИВНОСТИ И БЕЗОПАСНОСТИ НЕИММУННЫХ МЕТОДОВ ЛЕЧЕНИЯ ХРОНИЧЕСКОГО ГЛОМЕРУЛОНЕФРИТА, ПРОТЕКАЮЩЕГО БЕЗ НЕФРОТИЧЕСКОГО СИНДРОМА
О В Синяченко, Г. А. Игнатенко, Игорь Витальевич Мухин · Nephrology (Saint-Petersburg) · 2005
THE AIM of the investigation was to analyze effects of nonimmune methods of treatment for chronic glomerulonephritis on parameters of activity of renal immuneinflammatory process, evaluation of efficacy and safety of such therapy. PATIENTS AND METHODS. The examined 1310 patients with chronic glomerulonephritis with normal function of the kidneys were divided into 9 groups: 1 375 patients receiving treatment with inhibitors of angiotensin converting enzyme; 2 27 patients receiving blockers of receptors of angiotensin2; 3 193 patients receiving blockers of calcium channels of verapamil or diltiazem group (retard verapamil 180240 mg/day or diltiazem 90240 mg/day); 4 536 patients treated with dipiridamol 150400 mg/day; 5 51 patients receiving nonsteroid antiinflammatory drugs nimesulid 100 mg 2 times a day or celecocsib 100 mg 12 times a day; 6 17 patients treated with statins (lovastatin 1040 mg/day or simvastatin 2040 mg/day or athorvastatin 2080 mg/day); 7 25 patients treated with cod liver oil 1500 mg/day; 8 12 patients given ticlopidin 500 mg/day; 9 47 patients given vitamin E. Investigation of diurnal proteinuria, fibronectinuria, creatininemia, cholesterinemia, triglyceridemia, kaliemia, finrinogenemia and glomerular filtration rates was carried out in all patients prior to the beginning of treatment and within 7.5 month after the beginning of therapy. RESULTS. Inhibitors of angiotensin converting enzyme, blockers of angiotensin2 receptors, blockers of calcium channels, dipiridamol, ticlopidin and nonsteroid antiinflammatory drugs have an ability to decrease the degree of proteinuria. All antihypertensive drugs under study can lower the fibronectin level in urine that is evidence of processes of inhibition of sclerosing renal interstitium. Blockers of angiotensin2 receptors, blockers of calcium channels of the verapamil or diltiazem group, statins and fish oil decreased the parameters of lipidemia in different degrees. Blockers of angiotensin 2 receptors and ticlopidin accelerated the glomerular filtration rate and decreased fibrinogenemia. When inhibitors of angiotensin converting enzyme were used the augmentation of creatinine concentration in blood serum was noted. Inhibitors of angiotensin converting enzyme and nonsteroid antiinflammatory drugs caused the development of hyperkalemia. The most frequent side effects of treatment were: tussis, transitional hyperazotemia and hyperkalemia when inhibitors of angiotensin converting enzyme were used; headache was caused by dipiridamol; nonsteroid antiinflammatory drugs caused interstitial nephritis, gastropathy and liquid retention; statins caused myopathy; ticlopidin neutropenia and hemorrhagic diathesis. CONCLUSION. Groups of medicines used in the work had favorable effects upon different pathogenetic nonimmune mechanisms of progression of glomerulonephritis.
Cited by 0 works. doi:10.24884/1561-6274-2005-9-1-39-46